Locations:
Search IconSearch
August 20, 2024/Neurosciences/Brain Tumor

Medical and Surgical Management of Pituitary Disorders (Podcast)

A range of pituitary tumor-related conditions all benefit from a multidisciplinary approach

Although usually noncancerous, pituitary tumors are complex disorders and can produce multifaceted effects that manifest throughout the body. For this reason, their optimal management often requires a multidisciplinary approach.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“For the most favorable outcomes, it’s important that patients with pituitary tumors be treated at a dedicated pituitary center with various specialists who have expertise in dealing with these rare conditions,” says neuroendocrinologist Divya Yogi-Morren, MD, Medical Director of Cleveland Clinic’s Pituitary Center.

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Yogi-Morren joins neurosurgeon Pablo Recinos, MD, Section Head of Skull Base Surgery at Cleveland Clinic, to explore the essentials of managing pituitary tumors and other pituitary disorders. They jointly cover the following:

  • Various types of pituitary disorders, including acromegaly, Cushing’s disease, hypopituitarism, pituitary apoplexy, pituitary cysts and craniopharyngiomas
  • The diagnostic workup
  • Medical management
  • Surgical approaches
  • The importance of a dedicated pituitary center and a multidisciplinary team

Click the podcast player above to listen to the 36-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: Tell us about the diagnostic workup for a patient with a suspected pituitary tumor.

Divya Yogi-Morren, MD: We of course use evidence-based guidelines from the major endocrine societies to standardize our diagnostic approaches and inform our treatment decisions. Basically, we begin with the hormone evaluation, which I've already spoken about. We also have to do dynamic testing for pituitary tumors — sometimes to evaluate pituitary reserve, but also to evaluate the behavior of the tumor and how the tumor is producing its hormones. That's critical from the endocrine standpoint.

Advertisement

We also use MRI, which is the gold standard for visualizing pituitary tumors. Sometimes we also have to do something called inferior petrosal sinus sampling. This involves sampling blood from the inferior petrosal sinuses that drain the pituitary and then measuring hormone levels there. We enlist our neurointerventional radiologist colleagues to perform that procedure.

When it comes to monitoring, we also need to do visual field testing with our neuro-ophthalmologist. So we definitely need a variety of tools and specialists in order to diagnose these conditions correctly before patients can undergo surgery or radiation or any other intervention.

Glen Stevens, DO, PhD: I imagine that some providers out there may just order an MRI. But you have a very specific protocol where you do a pituitary-specific MRI and obtain the important sequences in that area, correct?

Pablo Recinos, MD: Absolutely. And it actually depends on whether we're looking from a diagnostic perspective or from a surgical perspective. In the latter context, we use MRI to provide GPS-like image guidance to inform the surgery.

Advertisement

Related Articles

Pituitary gland

Surgical Management of Giant Prolactinomas

Analysis examines surgical resection of rare pituitary tumors

Pituitary gland
October 11, 2022/Neurosciences/Brain Tumor

Does Extended Use of Prophylactic Antibiotics Improve Nasal Healing After Endoscopic Transsphenoidal Surgery?

Randomized controlled trial finds no quality-of-life benefit after standard pituitary tumor surgery

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

Ad